These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Tumor delineation using PET in head and neck cancers: threshold contouring and lesion volumes. Ford EC; Kinahan PE; Hanlon L; Alessio A; Rajendran J; Schwartz DL; Phillips M Med Phys; 2006 Nov; 33(11):4280-8. PubMed ID: 17153406 [TBL] [Abstract][Full Text] [Related]
23. Primary tumor delineation based on (18)FDG PET for locally advanced head and neck cancer treated by chemo-radiotherapy. Leclerc M; Lartigau E; Lacornerie T; Daisne JF; Kramar A; Grégoire V Radiother Oncol; 2015 Jul; 116(1):87-93. PubMed ID: 26088157 [TBL] [Abstract][Full Text] [Related]
24. Phantom validation of coregistration of PET and CT for image-guided radiotherapy. Lavely WC; Scarfone C; Cevikalp H; Li R; Byrne DW; Cmelak AJ; Dawant B; Price RR; Hallahan DE; Fitzpatrick JM Med Phys; 2004 May; 31(5):1083-92. PubMed ID: 15191296 [TBL] [Abstract][Full Text] [Related]
25. FDG-PET/CT imaging for staging and radiotherapy treatment planning of head and neck carcinoma. Deantonio L; Beldì D; Gambaro G; Loi G; Brambilla M; Inglese E; Krengli M Radiat Oncol; 2008 Sep; 3():29. PubMed ID: 18801181 [TBL] [Abstract][Full Text] [Related]
26. Adaptive dose painting by numbers for head-and-neck cancer. Duprez F; De Neve W; De Gersem W; Coghe M; Madani I Int J Radiat Oncol Biol Phys; 2011 Jul; 80(4):1045-55. PubMed ID: 20643512 [TBL] [Abstract][Full Text] [Related]
27. Initial experience of FDG-PET/CT guided IMRT of head-and-neck carcinoma. Wang D; Schultz CJ; Jursinic PA; Bialkowski M; Zhu XR; Brown WD; Rand SD; Michel MA; Campbell BH; Wong S; Li XA; Wilson JF Int J Radiat Oncol Biol Phys; 2006 May; 65(1):143-51. PubMed ID: 16618577 [TBL] [Abstract][Full Text] [Related]
28. Is image registration of fluorodeoxyglucose-positron emission tomography/computed tomography for head-and-neck cancer treatment planning necessary? Fried D; Lawrence M; Khandani AH; Rosenman J; Cullip T; Chera BS Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):748-54. PubMed ID: 22414285 [TBL] [Abstract][Full Text] [Related]
29. Can FDG-PET assist in radiotherapy target volume definition of metastatic lymph nodes in head-and-neck cancer? Schinagl DA; Hoffmann AL; Vogel WV; van Dalen JA; Verstappen SM; Oyen WJ; Kaanders JH Radiother Oncol; 2009 Apr; 91(1):95-100. PubMed ID: 19285354 [TBL] [Abstract][Full Text] [Related]
30. Automated functional image-guided radiation treatment planning for rectal cancer. Ciernik IF; Huser M; Burger C; Davis JB; Szekely G Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):893-900. PubMed ID: 15936575 [TBL] [Abstract][Full Text] [Related]
31. Impact of the type of imaging modality on target volumes delineation and dose distribution in pharyngo-laryngeal squamous cell carcinoma: comparison between pre- and per-treatment studies. Geets X; Daisne JF; Tomsej M; Duprez T; Lonneux M; Grégoire V Radiother Oncol; 2006 Mar; 78(3):291-7. PubMed ID: 16499982 [TBL] [Abstract][Full Text] [Related]
32. Intraobserver and interobserver variability in GTV delineation on FDG-PET-CT images of head and neck cancers. Breen SL; Publicover J; De Silva S; Pond G; Brock K; O'Sullivan B; Cummings B; Dawson L; Keller A; Kim J; Ringash J; Yu E; Hendler A; Waldron J Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):763-70. PubMed ID: 17379435 [TBL] [Abstract][Full Text] [Related]
33. Automated 3-dimensional registration of stand-alone (18)F-FDG whole-body PET with CT. Slomka PJ; Dey D; Przetak C; Aladl UE; Baum RP J Nucl Med; 2003 Jul; 44(7):1156-67. PubMed ID: 12843232 [TBL] [Abstract][Full Text] [Related]
34. Therapeutic optimization in head and neck radiotherapy planning: Advocacy for Nevesny S; Flaus A; Ailloud A; Sotton S; Prevot N; Guy JB; Magné N Bull Cancer; 2022 Dec; 109(12):1262-1268. PubMed ID: 36283891 [TBL] [Abstract][Full Text] [Related]
35. A feasibility study of 18F-fluorodeoxyglucose positron emission tomography targeting and simultaneous integrated boost for intensity-modulated radiosurgery and radiotherapy. Solberg TD; Agazaryan N; Goss BW; Dahlbom M; Lee SP J Neurosurg; 2004 Nov; 101 Suppl 3():381-9. PubMed ID: 15537193 [TBL] [Abstract][Full Text] [Related]
36. ¹⁸F-FDG-PET imaging in radiotherapy tumor volume delineation in treatment of head and neck cancer. Delouya G; Igidbashian L; Houle A; Bélair M; Boucher L; Cohade C; Beaulieu S; Filion EJ; Coulombe G; Hinse M; Martel C; Després P; Nguyen-Tan PF Radiother Oncol; 2011 Dec; 101(3):362-8. PubMed ID: 21885143 [TBL] [Abstract][Full Text] [Related]
37. Role of PET/CT in treatment planning for head and neck cancer patients undergoing definitive radiotherapy. Arslan S; Abakay CD; Sen F; Altay A; Akpinar T; Ekinci AS; Esbah O; Uslu N; Kekilli KE; Ozkan L Asian Pac J Cancer Prev; 2014; 15(24):10899-903. PubMed ID: 25605198 [TBL] [Abstract][Full Text] [Related]
39. Workflow and radiation safety implications of (18)F-FDG PET/CT scans for radiotherapy planning. Sam S; Shon IH; Vinod SK; Lin P; Lin M J Nucl Med Technol; 2012 Sep; 40(3):175-7. PubMed ID: 22582005 [TBL] [Abstract][Full Text] [Related]
40. The application of positron emission tomography/computed tomography in radiation treatment planning: effect on gross target volume definition and treatment management. Iğdem S; Alço G; Ercan T; Unalan B; Kara B; Geceer G; Akman C; Zengin FO; Atilla S; Okkan S Clin Oncol (R Coll Radiol); 2010 Apr; 22(3):173-8. PubMed ID: 20116979 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]